NCT06298006 · ACTIVE NOT RECRUITING

A Two Year Longitudinal Clinical Study of Neurocognitive and Psychiatric Symptoms in Post COVID-19 Patients

This study follows people who developed cognitive or psychological symptoms after a COVID-19 infection, tracking them over two years. Researchers are measuring how brain fog, mood changes, and thinking difficulties evolve over time, and looking for markers that might predict who improves or stays impaired. There is no treatment being tested here — it is purely observational, meaning researchers watch and record, they do not intervene.

You may qualify if

  • neurocognitive symptoms after lab-verified COVID-19 infection

You're excluded if

  • severe illness e.g cancer with a short expected survival time
  • ongoing alcohol abuse
  • ongoing drug abuse.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-02-11

View full record on ClinicalTrials.gov

All APOE4 clinical trials